contact us Contact Us Or call +44 (0)118 979 1169
  • About
    • Who are GRA?
    • Meet Lee
    • Associates
    • Testimonials
    • FAQs
  • Services
    • Biotech Consulting
    • Biotech Speaker
    • Training
  • Blog
  • Contact Us
  • Case Studies
  • Resources
    • Articles
    • Videos
    • Presentations
    • Free Templates
    • Newsletters
  • Search
  • Client Login
    • Trello
    • GoToMeeting
    • join me
  • Services
  • Biotech Consulting
    • Regulatory Affairs (RA)
    • Quality by Design (QbD)
    • Formulation Development
    • Vaccine Development
    • Process Characterization
    • Cell & Seed Bank Characterization
    • CMC
    • Commercial Support
    • Biotech Due Diligence
    • Product Characterisation
    • CMO Management
    • Licencing
    • Design of Experiments (DoE)
    • Process Validation
    • Analytical Development
  • Biotech Speaker
  • Training

Regulatory Affairs (RA)

The regulatory elements of product’s development are a key component of getting a new product efficiently and successfully onto the market.  Given the time, effort and expense required to complete your submission, a dynamic regulatory strategy will ensure that you minimise risk and maximise speed in making submissions to gain the approval required.  GRA is able to advise on the most suitable regulatory strategy that spans product development with knowledge of both European and the US approval procedures.  We can help you to plan your submission routes and define which countries you should access first through to being hands on and actually writing the dossier with your appropriate input.

GreyRigge’s associates have many years experience of compiling dossiers, whether Clinical Trial Applications (CTA), Scientific Advice or Marketing Authorisation Applications.  We would partner with you to help compile your dossier to meet the planned milestone to get your product into the clinic as soon as possible.  Furthermore, we can also advise on post-licencing activities to ensure that products remain complaint with the latest regulations and what changes might be made to the product or process.

Ultimately we provide targeted solutions for the development and approval of your biopharmaceutical products.  We understand all facets of biopharmaceutical development as well as understanding the agencies in Europe and the U.S.  Most importantly we recognise the interests of our clients and that this is a business thus bring pragmatic, valid and compliant approaches to your products.

 

 

  • need to get in touch? Contact GRA Email GRA +44 (0) 118 979 1169
  • Stay up
    to date

    Complete your details and we’ll send you regular updates via our newsletter.

  • Our newsletter



    • Resources

      Need to understand some element of the biopharma industry or looking for a particular template?

      Click here to see our free resources

    • About
      • Who are GRA?
      • Meet Lee
      • Associates
      • Testimonials
      • FAQs
    • Services
      • Biotech Consulting
      • Biotech Speaker
      • Training
    • Blog
    • Contact Us
    • Case Studies
    • Resources
      • Articles
      • Videos
      • Presentations
      • Free Templates
      • Newsletters
    Terms & Conditions Privacy Policy Cookies FAQs

    © 2023 GreyRigge Associates Limited. All rights reserved.

    Site design & build by Hinge Ltd.